Activity Details (PDF Format)
	Course Materials (PDF Format)
	Download Slides
	Participate in On Demand Activity
	Complete Post-Test/ Print CE Certificate
	Faculty
	Statement of Need
	Activity Goal
	Learning Objectives
	Target Audience
	Financial Support
	Credit Information

Premiere Date: Monday, March 13, 2006
Live Audioconference Series (12 sessions): March - May 2006

This activity offers CE credit for:

1. Physicians (ACCME/AMA PRA Category 1)
2. Nurses (ANCC)
3. Pharmacists (ACPE)
4. Psychologists (APA)
5. Social Workers (NASW)
6. Certified Case Managers (CCMC)

All other clinicians will either receive a CME Attendance Certificate or may choose any of the types of CE credit being offered.
Credit Expiration Date:
Thursday, May 10, 2007

Faculty

Jeffrey A. Lieberman, MD Chairman, Department of Psychiatry College of Physicians and Surgeons, Columbia University Director, New York State Psychiatric Institute Director, Lieber Center for Schizophrenia Research Psychiatrist-in-Chief at New York Presbyterian Hospital & Columbia University Medical Center New York, NY

Scott Stroup, MD, MPH Associate Professor of Psychiatry Adjunct Associate Professor of Social Medicine University of North Carolina-Chapel Hill Chapel Hill, NC

Faculty Bios and Disclosure Declaration

All faculty participating in CME Outfitters continuing education activities are required to disclose any conflict(s) of interest related to the content of their presentation(s) as defined by the ACCME's Standards for Commercial Support, and other accrediting and regulatory bodies. Full disclosure of faculty relationships will be made prior to registration availability for this activity on this website and within the activity syllabus/course guide.

Statement of Need

The Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) trial has provided, for the first time, detailed information comparing the efficacy and side effects of existing treatments for schizophrenia. This NIMH-sponsored study assessed 1,460 people between the ages of 18 and 65 who met DSM-IV criteria for schizophrenia. Participants were recruited from the community at large, assigned to interventions already in relatively widespread use, and followed for 18 months. If at any time during the trial an assigned medication was ineffective or not well tolerated, patients were re-randomized to other treatment pathways. To emulate real-world patterns of schizophrenia, CATIE included people with medical comorbidities, substance use disorders, and those currently treated with other medications. Data collection in the study was completed in December 2004, with the initial analysis published in September 2005. The primary outcome of CATIE is all-cause treatment discontinuation, an important clinical endpoint that reflects both clinician and patient judgements about efficacy and tolerability. Secondary outcome measures of CATIE include symptoms, side effects, neurocognitive functioning, and cost-effectiveness. In this evidence-based psychCME activity, CATIE researchers will expand on the initial outcome data, emphasize the importance of providing individualized treatment strategies for patients with schizophrenia, and offer a contextual framework for making responsible, real-world decisions about treating these challenging patients.

---

Lieberman J, Stroup TS, McEvoy JP, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005;353:1209-1223.
Stroup TS, McEvoy JP, Swartz MS, et al. The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development. Schizophr Bull 2003;29:15-31.

Activity Goal

To disseminate current and clinically relevant information about the efficacy and side effects of different agents used to treat schizophrenia.

Learning Objectives

At the end of this CE activity, participants should be able to:

• Compare and contrast the efficacy of the various agents in the CATIE trial.
• Apply a contextual framework to the CATIE results as new data become available.
• Identify the factors involved in providing individualized treatment strategies for patients with schizophrenia.

Target Audience

Physicians, physician assistants, nurse practitioners, nurses, psychologists, social workers, certified case managers, pharmacists, and other healthcare professionals with an interest in mental health.

Financial Support

CME Outfitters, LLC, gratefully acknowledges an educational grant from Eli Lilly and Company in support of this CE activity.

Credit Information

CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. CME Outfitters, LLC, designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Note to Physician Assistants: AAPA accepts Category I credit from AOACCME, Prescribed credit from AAFP, and AMA Category I CME credit for the PRA from organizations accredited by ACCME.

CNE Credit (Nurses):
This Educational Activity is presented by CME Outfitters, LLC, which has been approved as a provider of continuing education by the New York State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. It has been assigned code 5UYSJZ-PRV- 0491. 1.0 contact hour (Pharmacology)

CEP Credit (Psychologists):
CME Outfitters, LLC, is approved by the American Psychological Association to sponsor continuing education for psychologists. CME Outfitters, LLC, maintains responsibility for this program and its content. (1.0 CE credits)

NASW Credit (Social Workers):
This program was approved by the National Association of Social Workers (provider #886407722) for 1 continuing education contact hour.

CCMC Credit (Certified Case Managers):
This program has been approved for 1 hour by the Commission for Case Manager Certification (CCMC).

CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.0 contact hours (0.1 CEUs)
Universal Program Number: 376-999-06-007-L01 (live interactive session) 376-999-06-007-H01 (recorded activities)

To receive credit, participants must review all activity materials in their entirety, score 70% or above on a post-test, and fully complete and return both the credit request form and activity evaluation. A certificate or statement of credit will be mailed within 4-6 weeks to all who successfully complete these requirements.

Questions about this CE activity? Call us at 877.CME.PROS (877.263.7767).

TK-009-031306-11